ArticleJournal of mass spectrometry and advances in the clinical lab2021

Ravulizumab: Characterization and quantitation of a new C5 inhibitor using isotype specific affinity purification and high-resolution mass spectrometry.

Paula M Ladwig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.